iRadimed (NASDAQ:IRMD) CEO Sells $356,350.00 in Stock

Key Points

• Roger Susi, CEO of iRadimed Corporation, sold 5,000 shares of stock for a total of $356,350 on September 17th, reducing his ownership by 0.21%.
• iRadimed recently declared a quarterly dividend of $0.17 per share, with an annualized dividend yield of 0.9%.
• Institutional investors hold 92.34% of iRadimed's stock, with several firms increasing their holdings notably in recent quarters.

iRadimed Corporation (NASDAQ:IRMD - Get Free Report) CEO Roger E. Susi sold 5,000 shares of the company's stock in a transaction that occurred on Wednesday, September 17th. The shares were sold at an average price of $71.27, for a total transaction of $356,350.00. Following the sale, the chief executive officer owned 2,357,500 shares in the company, valued at $168,019,025. The trade was a 0.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

iRadimed Trading Up 0.3%

Shares of NASDAQ:IRMD traded up $0.19 during trading on Monday, reaching $70.71. The company had a trading volume of 56,480 shares, compared to its average volume of 42,599. The company has a fifty day moving average of $67.56 and a two-hundred day moving average of $59.28. The stock has a market capitalization of $899.43 million, a P/E ratio of 43.53 and a beta of 1.01. iRadimed Corporation has a 12 month low of $46.86 and a 12 month high of $74.43.

iRadimed Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, August 28th. Shareholders of record on Monday, August 18th were given a dividend of $0.17 per share. The ex-dividend date of this dividend was Monday, August 18th. This represents a $0.68 annualized dividend and a yield of 1.0%. iRadimed's dividend payout ratio is presently 41.98%.

Institutional Investors Weigh In On iRadimed

Institutional investors and hedge funds have recently modified their holdings of the stock. Jump Financial LLC increased its stake in iRadimed by 4.9% during the 1st quarter. Jump Financial LLC now owns 4,300 shares of the medical equipment provider's stock valued at $226,000 after purchasing an additional 200 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in iRadimed by 4.7% during the fourth quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 4,577 shares of the medical equipment provider's stock valued at $252,000 after purchasing an additional 204 shares in the last quarter. First Horizon Advisors Inc. lifted its holdings in shares of iRadimed by 78.7% in the first quarter. First Horizon Advisors Inc. now owns 513 shares of the medical equipment provider's stock worth $27,000 after buying an additional 226 shares in the last quarter. Martingale Asset Management L P lifted its holdings in shares of iRadimed by 2.4% in the first quarter. Martingale Asset Management L P now owns 12,831 shares of the medical equipment provider's stock worth $673,000 after buying an additional 300 shares in the last quarter. Finally, State of Wyoming raised its stake in iRadimed by 11.3% during the first quarter. State of Wyoming now owns 3,013 shares of the medical equipment provider's stock valued at $158,000 after purchasing an additional 307 shares in the last quarter. 92.34% of the stock is owned by hedge funds and other institutional investors.

About iRadimed

IRadimed Corp. engages in the development, manufacture, marketing, and distribution of Magnetic Resonance Imaging compatible medical devices. It also provides a non-magnetic Intravenous infusion pump system that is specifically designed for use during MRI procedures. The company was founded by Roger Susi in July 1992 and is headquartered in Winter Springs, FL.